| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3926770 | European Urology Supplements | 2009 | 6 Pages |
Abstract
This paper describes the development of PCA3-based molecular urine tests, and we also review the most recent data demonstrating the potential diagnostic and prognostic utilities of PCA3 and the initial findings of the TMPRSS2-ERG gene fusion testing.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Jack A. Schalken,